Mindfulness for Intense Emotions: A Feasibility Trial
Launched by CANTERBURY CHRIST CHURCH UNIVERSITY · Jul 26, 2016
Trial Information
Current as of May 23, 2025
Withdrawn
Keywords
ClinConnect Summary
This is an uncontrolled feasibility trial of an eight-week mindfulness-based intervention for people with a diagnosis of borderline personality disorder. A battery of measures will be administered at baseline, in a time window of six to zero weeks prior to the start of the intervention. Outcome measures will be repeated in the two weeks after the end of the eight-week intervention, along with a qualitative interview.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Are on the caseload of a United Kingdom National Health Service Assessment and Treatment Service in the recruitment area and have had contact with that service in the past three months
- • Have received the diagnosis of Borderline Personality Disorder from a suitably qualified health care professional, and continue to meet criteria for this diagnosis according to the SCID-II (Structured Clinical Interview for DSM Disorders Version II) at their screening assessment
- • Have sufficient English language speaking and comprehension abilities to access group discussions and hand-out materials
- • Have not previously engaged in a mindfulness-based intervention. As in other similar trials, a minimum dose has been operationally defined as having undertaken 50% or more of a mindfulness-based intervention delivered face-to-face by a suitably qualified health care professional
- • Are not currently receiving, nor have plans to receive any other form of psychological therapy during the course of the study
- Exclusion criteria:
- • Have psychosis
- • Misuse alcohol or drug to a level that requiring detox
- • Have a intellectual disability
- • Present a high level of risk requiring inpatient management at the time of their screening assessment
About Canterbury Christ Church University
Canterbury Christ Church University is a leading higher education institution in the UK, renowned for its commitment to research excellence and community engagement. With a strong focus on health and social care, the university undertakes a range of clinical trials aimed at advancing medical knowledge and improving patient outcomes. By leveraging interdisciplinary collaboration and state-of-the-art facilities, Canterbury Christ Church University strives to contribute valuable insights to the scientific community while fostering innovation in healthcare practices. Its dedicated team of researchers and practitioners work diligently to ensure the highest standards of ethical conduct and scientific rigor in all clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brighton, Sussex, United Kingdom
Patients applied
Trial Officials
Hannah Droscher
Principal Investigator
Canterbury Christ Church University
Clara Strauss
Study Director
Sussex Partnership NHS Foundation Trust
Helen Startup
Study Director
Sussex Partnership NHS Foundation Trust
Fergal Jones
Study Director
Canterbury Christ Church University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials